Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 13, 2015
0Patent Application Number
138556400
Date Filed
April 2, 2013
0Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Disclosed are tyrosine-modified rAAV vectors, as well as infectious virions, compositions, and pharmaceutical formulations that comprise them. Also disclosed are methods of preparing and methods for using the disclosed tyrosine-phosphorylated capsid protein mutant rAAV vectors in a variety of diagnostic and therapeutic applications including in vivo and ex vivo gene therapy, and large-scale production of rAAV vectors.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
